Cite
HARVARD Citation
Bennett, J. et al. (2022). IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies. Current opinion in hematology. 29 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bennett, J. et al. (2022). IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies. Current opinion in hematology. 29 (1), p. . [Online].